Matthew T Cooper - Net Worth and Insider Trading

Matthew T Cooper Net Worth

The estimated net worth of Matthew T Cooper is at least $1,269 dollars as of 2024-05-28. Matthew T Cooper is the Chief Scientific Officer of Biora Therapeutics Inc and owns about 2,137 shares of Biora Therapeutics Inc (BIOR) stock worth over $1,269. Details can be seen in Matthew T Cooper's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew T Cooper has not made any transactions after 2020-09-03 and currently still holds the listed stock(s).

Transaction Summary of Matthew T Cooper

To

Matthew T Cooper Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew T Cooper owns 1 companies in total, including Biora Therapeutics Inc (BIOR) .

Click here to see the complete history of Matthew T Cooper’s form 4 insider trades.

Insider Ownership Summary of Matthew T Cooper

Ticker Comapny Transaction Date Type of Owner
BIOR Biora Therapeutics Inc 2020-09-03 Chief Scientific Officer

Matthew T Cooper Latest Holdings Summary

Matthew T Cooper currently owns a total of 1 stock. Matthew T Cooper owns 2,137 shares of Biora Therapeutics Inc (BIOR) as of September 3, 2020, with a value of $1,269.

Latest Holdings of Matthew T Cooper

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIOR Biora Therapeutics Inc 2020-09-03 2,137 0.59 1,269

Holding Weightings of Matthew T Cooper


Matthew T Cooper Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew T Cooper has made a total of 1 transactions in Biora Therapeutics Inc (BIOR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Biora Therapeutics Inc is the acquisition of 370 shares on September 3, 2020, which cost Matthew T Cooper around $79,088.

Insider Trading History of Matthew T Cooper

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew T Cooper Trading Performance

GuruFocus tracks the stock performance after each of Matthew T Cooper's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew T Cooper is -60.62%. GuruFocus also compares Matthew T Cooper's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew T Cooper within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew T Cooper's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew T Cooper

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.06
Relative Return to S&P 500(%) 15.15

Matthew T Cooper Ownership Network

Ownership Network List of Matthew T Cooper

No Data

Ownership Network Relation of Matthew T Cooper


Matthew T Cooper Owned Company Details

What does Biora Therapeutics Inc do?

Who are the key executives at Biora Therapeutics Inc?

Matthew T Cooper is the Chief Scientific Officer of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Capital Management, Lp .

Biora Therapeutics Inc (BIOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biora Therapeutics Inc Insider Transactions

No Available Data

Matthew T Cooper Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew T Cooper. You might contact Matthew T Cooper via mailing address: 4330 La Jolla Village Drive, Suite 200, San Diego Ca 92122.

Discussions on Matthew T Cooper

No discussions yet.